Annual D&A
$107.67 M
+$53.49 M+98.73%
December 31, 2023
Summary
- As of February 7, 2025, GDRX annual depreciation & amortization is $107.67 million, with the most recent change of +$53.49 million (+98.73%) on December 31, 2023.
- During the last 3 years, GDRX annual D&A has risen by +$89.24 million (+484.20%).
- GDRX annual D&A is now at all-time high.
Performance
GDRX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$17.54 M
+$570.00 K+3.36%
September 30, 2024
Summary
- As of February 7, 2025, GDRX quarterly depreciation & amortization is $17.54 million, with the most recent change of +$570.00 thousand (+3.36%) on September 30, 2024.
- Over the past year, GDRX quarterly D&A has dropped by -$15.49 million (-46.90%).
- GDRX quarterly D&A is now -59.79% below its all-time high of $43.61 million, reached on December 31, 2023.
Performance
GDRX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$94.05 M
-$15.49 M-14.14%
September 30, 2024
Summary
- As of February 7, 2025, GDRX TTM depreciation & amortization is $94.05 million, with the most recent change of -$15.49 million (-14.14%) on September 30, 2024.
- Over the past year, GDRX TTM D&A has increased by +$14.46 million (+18.16%).
- GDRX TTM D&A is now -14.14% below its all-time high of $109.54 million, reached on June 30, 2024.
Performance
GDRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
GDRX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +98.7% | -46.9% | +18.2% |
| 3 y3 years | +484.2% | -46.9% | +18.2% |
| 5 y5 years | +998.0% | -46.9% | +18.2% |
GDRX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +211.7% | -59.8% | +64.7% | -14.1% | +172.3% |
| 5 y | 5-year | at high | +693.3% | -59.8% | +303.6% | -14.1% | +2064.6% |
| alltime | all time | at high | +998.0% | -59.8% | +303.6% | -14.1% | +2064.6% |
GoodRx Holdings Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $17.54 M(+3.4%) | $94.05 M(-14.1%) |
| Jun 2024 | - | $16.96 M(+6.4%) | $109.54 M(+0.8%) |
| Mar 2024 | - | $15.94 M(-63.4%) | $108.67 M(+0.9%) |
| Dec 2023 | $107.67 M(+98.7%) | $43.61 M(+32.0%) | $107.67 M(+35.3%) |
| Sep 2023 | - | $33.02 M(+105.2%) | $79.59 M(+31.5%) |
| Jun 2023 | - | $16.10 M(+7.8%) | $60.52 M(+4.8%) |
| Mar 2023 | - | $14.94 M(-3.8%) | $57.74 M(+6.6%) |
| Dec 2022 | $54.18 M | $15.53 M(+11.3%) | $54.18 M(+9.9%) |
| Sep 2022 | - | $13.95 M(+4.8%) | $49.29 M(+8.3%) |
| Jun 2022 | - | $13.32 M(+17.1%) | $45.50 M(+12.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $11.37 M(+6.8%) | $40.55 M(+17.4%) |
| Dec 2021 | $34.54 M(+87.4%) | $10.65 M(+4.8%) | $34.54 M(+22.1%) |
| Sep 2021 | - | $10.16 M(+21.4%) | $28.30 M(+21.5%) |
| Jun 2021 | - | $8.37 M(+56.1%) | $23.29 M(+19.8%) |
| Mar 2021 | - | $5.36 M(+21.7%) | $19.45 M(+5.5%) |
| Dec 2020 | $18.43 M(+35.8%) | $4.40 M(-14.7%) | $18.43 M(+31.4%) |
| Sep 2020 | - | $5.16 M(+14.1%) | $14.03 M(+58.2%) |
| Jun 2020 | - | $4.52 M(+4.1%) | $8.87 M(+104.1%) |
| Mar 2020 | - | $4.34 M | $4.34 M |
| Dec 2019 | $13.57 M(+38.4%) | - | - |
| Dec 2018 | $9.81 M | - | - |
FAQ
- What is GoodRx Holdings annual depreciation & amortization?
- What is the all time high annual D&A for GoodRx Holdings?
- What is GoodRx Holdings annual D&A year-on-year change?
- What is GoodRx Holdings quarterly depreciation & amortization?
- What is the all time high quarterly D&A for GoodRx Holdings?
- What is GoodRx Holdings quarterly D&A year-on-year change?
- What is GoodRx Holdings TTM depreciation & amortization?
- What is the all time high TTM D&A for GoodRx Holdings?
- What is GoodRx Holdings TTM D&A year-on-year change?
What is GoodRx Holdings annual depreciation & amortization?
The current annual D&A of GDRX is $107.67 M
What is the all time high annual D&A for GoodRx Holdings?
GoodRx Holdings all-time high annual depreciation & amortization is $107.67 M
What is GoodRx Holdings annual D&A year-on-year change?
Over the past year, GDRX annual depreciation & amortization has changed by +$53.49 M (+98.73%)
What is GoodRx Holdings quarterly depreciation & amortization?
The current quarterly D&A of GDRX is $17.54 M
What is the all time high quarterly D&A for GoodRx Holdings?
GoodRx Holdings all-time high quarterly depreciation & amortization is $43.61 M
What is GoodRx Holdings quarterly D&A year-on-year change?
Over the past year, GDRX quarterly depreciation & amortization has changed by -$15.49 M (-46.90%)
What is GoodRx Holdings TTM depreciation & amortization?
The current TTM D&A of GDRX is $94.05 M
What is the all time high TTM D&A for GoodRx Holdings?
GoodRx Holdings all-time high TTM depreciation & amortization is $109.54 M
What is GoodRx Holdings TTM D&A year-on-year change?
Over the past year, GDRX TTM depreciation & amortization has changed by +$14.46 M (+18.16%)